LYEL vs NEE · rev $61.0K vs P/E 28, $153.16B cap
Lyell Immunopharma Inc (LYEL) versus Nextera Energy Inc (NEE) — a side-by-side from cached financials, not a winner call.
Lyell Immunopharma Inc (LYEL) is a biotechnology company listed on US.
Nextera Energy Inc (NEE) is a utilities - regulated electric company listed on US.
Latest reported LYEL revenue for 2024-12-31 was $61.0K. Net income was -$343.0M. Revenue was down 53.1% from 2023-12-31 to 2024-12-31. LYEL currently screens at market cap $143.5M.
NEE does not have a complete income-statement cache yet.
LYEL currently screens at market cap $143.5M. NEE currently screens at market cap $153.16B and trailing P/E 27.9.
Not investment advice. Open the LYEL and NEE stock pages for the full models.
Not investment advice.